PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8845818

Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.

M Muratsugu·Y Miyake·N Ishida·A Hyodo·K Terayama
View original source ↗Export metadata ↓

Abstract

Treatment of Klebsiella pneumoniae 109 with cefodizime, ceftazidime, cefbuperazone, cefotaxime or flomoxef at a sub-minimum inhibitory concentration (sub-MIC) (1/4 MIC) for 1 h altered its morphology. The bacteria treated with cefodizime at sub-MICs (1/8, 1/4 MIC) enhanced the chemiluminescencence (CL) of human polymorphonuclear leucocytes (PMNs), implying an increase in the production of active oxygen species in association with phagocytosis, whereas the cells treated with other cephalosporins at the same sub-MICs did not. Furthermore, a significant decrease in electrophoretic mobility was induced by the bacteria treated with cefodizime at sub-MICs (1/8, 1/4 MIC), but other cephalosporins neither increased nor decreased the electrophoretic mobility significantly. These findings suggested that cefodizime caused a morphological change, with a decrease in negative surface charge density of K. pneumoniae, more easily than ceftazidime, cefbuperazone, cefotaxime or flomoxef, followed by an increase in the phagocytic activity of PMNs.

Explore related subjects

CefotaximeCephalosporinsElectrophoresisHumansKlebsiella pneumoniaeLuminescent MeasurementsMicrobial Sensitivity TestsNeutrophilsPhagocytosisSurface PropertiesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Muratsugu, Y Miyake, N Ishida, A Hyodo, K Terayama. 1995. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.. https://doi.org/10.1248/bpb.18.1259

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 beta-lactamase.

For a number of years a major limitation in genetic analysis of protein function has been the inability to introduce multiple substitutions at distant sites that would enable the selection of clusters of mutations required for improved or novel biological functions. In order to achieve this, we have recently developed a novel mutagenesis procedure in which the triphosphate derivatives of a pyrimidine (6-(2-deoxy-beta-d-ribofuranosyl)-3, 4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one; dP) and a purine (8-oxo-2'-deoxyguanosine; 8-oxodG) nucleoside analogue are employed in DNA synthesis reactions in vitro. The procedure allows control of the mutational load and can yield frequencies of amino acid residue substitutions at least one order of magnitude greater than those previously achieved. Here we report the results of an experiment in which we have hypermutated the bacterial enzyme TEM-1 beta-lactamase and selected small pools (<1.5x10(5)) of clones for enzymatic activity against the beta-lactam antibiotic cefotaxime. The experiment resulted in the isolation of a number of TEM-1 mutants with greatly improved activity against cefotaxime. Among these, clone 3D.5 (E104K:M182T:G238S) exhibited a minimum inhibitory concentration for cefotaxime 20,000-fold higher than wild-type TEM-1 and a catalytic efficiency (kcat/Km) 2383 times higher than the wild-type enzyme. Thus, small pools of hypermutated sequences enabled the selection of one of the most active extended beta-lactamases described so far. These results argue against the accepted view that multiple rounds of low-rate mutagenesis and stepwise selection are essential for in vitro protein evolution and extend the scope of directed molecular evolution to proteins for which no genetic selection is available.

Cefotaxime↗
PubMed1998

Anodic voltammetry of cefotaxime.

In this study electrooxidation of cefotaxime was investigated using specially activated glassy carbon (GC), platinum and carbon paste (CP) electrodes in different supporting electrolyte solutions and at different pHs. The data revealed that the shapes of the voltammograms and the numbers of the oxidation steps changed depending on the nature of the electrode. The nature of the supporting electrolyte was also important for the response of the electrode. From an analytical point of view, the activated GC electrode was the most favourable one. In 0.2 M H3PO4 with an activated GC electrode the calibration graph gave two lines with different slopes in the concentration ranges of 2 x 10(-5)-1 x 10(-4) and 2 x 10(-4)-6 x 10(-4). The results of the recovery test and statistical analysis showed that the voltammetric method could be used for the determination of cefotaxime.

Cefotaxime↗
PubMed1998

Derivative spectrophotometric determination of the triethylammonium salt of cefotaxime in presence of related compounds from the synthesis.

Cefotaxime sodium is a broad spectrum third generation antibiotic. It is obtained by reaction of 7-aminocephalosporanic acid (7-ACA) and S-(2-benzothiazolyl)2-amino-alpha-(methoxyimino)-4-thiazoleethanethio ate. 2-Mercaptobenzothiazole is a by-product of this reaction. A derivative spectrophotometric determination of cefotaxime is proposed for its determination in a reaction mixture in the presence of the related compounds from synthesis. With this method Beer's law is obeyed over a concentration range from 0.005 to 0.080 mg ml(-1) at 276.8 nm (r = 0.9995). This technique is accurate, precise (RSD = 0.4%), and has a sensitivity of 1.2% (differences in analytical response of 0.74 microg ml(-1) could be detected). Recovery experiments of cefotaxime from reaction mixtures include 100% for all assayed concentrations. For these reasons, this technique is found valid for the intended purposes.

Cefotaxime↗